Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

IMPE Abstracts

Published by BioScientifica
Volume 96 | IMPE2023

IMPE 2023

Buenos Aires, Argentina
04 Mar 2023 - 07 Mar 2023

Card image cap
11th International Meeting of Pediatric Endocrinology (IMPE 2023). 4 -7 March 2023 - Buenos Aires, Argentina.

ePoster Presentations

Fetal, Neonatal Endocrinology and Metabolism

Previous section
Fat, Metabolism and Obesity
Table of contents
Next section
GH and IGFs

impe0096ep33 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

Neonatal Screening Program In Argentina. 37 Years of experience at the Fundación de Endocrinología Infantil (FEI)

Enacán Rosa , Mendez Virginia , Santilli Alexia , Prieto Laura , Gruñeiro-Papendieck Laura , Bergadá Ignacio , Chiesa Ana

Background: Since August 1985 we started a neonatal screening program for 1) Congenital Hypothyroidism (CH) and 2) Phenylketonuria /Hyperphenylalaninemias PKU/HPA) adding to the program in 1997 3) Cystic Fibrosis (FQ) 4) Galactosemia (GAL) and 5) Congenital Adrenal Hyperplasia (CAH), in 2006 6) Biotinidase Deficiency (BD) and in 2013 7) Maple syrup disease (MSUD).Objective: To Communicate the results of the implemented p...
0 shares

impe0096ep34 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

Congenital Hyperinsulinism: review of cases after surgical treatment at the Hospital das Clínicas de Ribeirão Preto (HCRP), University of São Paulo

Junior Raphael Liberatore , Mataro Isabella , Pilegi Flavio

Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil Congenital hyperinsulinism (CH) causes severe hypoglycemia through inappropriate insulin secretion, with high rates of morbidity and mortality. Conservative treatment may not be sufficient for glycemic control and surgical treatment is necessary. HCRP has a treatment center for Congenital Hyperinsulinism. The purpose of this study was to review the clinical, laboratory and molec...
1 shares

impe0096ep35 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

ABSTRACT WITHDRAWN...
0 shares

impe0096ep36 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

ABSTRACT WITHDRAWN...
0 shares

impe0096ep37 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

Cyclic menses in a preterm infant

Giraudo Franco , Griffero Mariana , M Merino Paulina , Fernando Cassorla

Introduction: Minipuberty describes the transient sex-specific activation of the hypothalamic-pituitary-gonadal (HPG) axis during the first 2 years in girls. Data in preterm are scarce, but It seems that the HPG axis activation is more intense and prolonged compared with full-term infants, resulting in higher sex steroid concentrations, sometimes with extreme pubertal characteristics.Clinical case: A female infant presen...
0 shares

impe0096ep38 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

Early diagnosis of Kabuki syndrome in an infant with congenital hyperinsulinism

Thybo Christesen Henrik , Kjærsgaard Hansen Lars , Brusgaard Klaus

Background: Kabuki syndrome (KS) is a rare malformation and disability syndrome, associated with congenital hyperinsulinism (CHI) in 0.3-4%. Whereas CHI may be the overt already from day one of life, the median age at KS diagnosis is 11-16 months.Methods: Case reportResults: A term-born girl, birth weight 4550 g had unexpected hypoglycemia 1.8 mmol/L (32 mg/dL) day one of life with...
0 shares

impe0096ep39 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

Knowledge of Pregnant Women About The Benefits of Breastfeeding for The Baby's Health in The Short and Long Term.

Machado Pinto Renata , Adib Nery Aboud Arthur , Mendonça Macedo Rafael , Ferreira Matos Arthur , Menezes de Lima Filho Eduardo , Caetano Diniz Gabriel

The objective of this study was to determine the knowledge of pregnant women about the benefits of breastfeeding for the baby's health in the short and long term and also to compare the degree of knowledge with sociodemographic and clinical variables. This research is a cross-sectional, descriptive study, through questionnaires applied to pregnant women. Statistical analysis was performed with the SPSS 26.0 program, with a significance level of 5%. The questionnaire addre...
0 shares

impe0096ep40 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

Knowledge of Pregnant Women About "Developmental Programming" and The Importance of The 1000 Days for The Long-Term Health of The Baby

Machado Pinto Renata , Mendonça Macedo Rafael , Adib Nery Aboud Arthur , Ferreira Matos Arthur , Menezes de Lima Filho Eduardo , Caetano Diniz Gabriel

"Developmental Programming" (DP) refers to the long-term health effect determined by environmental exposures during the child's first 1000 days. This study aimed to determine pregnant women's knowledge about DP and compare the degree of knowledge with clinical and sociodemographic variables. This research is a cross-sectional, descriptive study carried out through a questionnaire applied to pregnant women. Statistical analysis was performed with the SPSS 26...
0 shares

impe0096ep41 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

Two cases of diffuse forms of diazoxide-responsive congenital hyperinsulinism with positive PET-CT findings

Yu Jeesuk , Yang Jaejin , Joo Son Hye

Congenital hyperinsulinism is one of the most common causes of severe hypoglycemia in infants. Case 1. A 9-year-old girl had her first hypoglycemic seizure at the age of 65 days. Her blood glucose, insulin, C-peptide, cortisol, and ammonia levels were 42 mg/dL, 37.14U/mL, 4.20 ng/mL, 21.85 mg/dL and 54 mg/dL, respectively. Diazoxide was started and she was referred to our Pediatric Endocrinology Clinic at 9 months. Genetic investigation, including whole exome sequencing, did n...
0 shares

impe0096ep42 | Fetal, Neonatal Endocrinology and Metabolism | IMPE2023

Pseudohypoaldosteronism type 1, a diagnosis of difficult clinical suspicion. Case report.

Acosta-Rodríguez Ariana , Mendoza-Rojas Victor

Pseudohypoaldosteronism (PHA) is a rare heterogeneous mineralocorticoid resistance syndrome caused by insufficient potassium and hydrogen secretion. PHA type1 (PHA1) causes neonatal salt loss, failure to thrive, dehydration, and circulatory shock. Two different forms of PHA1 can be distinguished on the clinical and genetic levels, showing either a systemic or a renal form. We present an infant with a clinical diagnosis of PHA1. A male 39-week newborn, presented on postnatal-da...
3 shares

Published by BioScientifica

IMPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more